Description: Most health care delivered in the United States is based on the acute care model: it is episodic has a beginning, middle and end usually the patient recovers and interventions are designed to target a specific pathophysiologic abnormality. Chronic disease care, in contrast, often has no clear beginning and no end the focus is on managing over the long term with prevention of progression and complications. Further, many chronic diseases “travel together” comorbidities: for example, diabetes, hypertension, coronary artery disease CAD, heart failure, cerebrovascular disease, peripheral arterial disease and renal dysfunction are often found together.

Description: An essay suggesting one solution in theory would be to create a system similar to Medicare Advantage for the entire American population.

Description: Essay states a competing American ideals for the U.S. Health care system include free markets which foster competition, cost effectiveness and quality health care vs.public and private assistance which provides health care independent of a person’s financial means.

Description: Author reply to Jay Olshansky’s discussion of “Health Expectancy” paper and reply from authors Faye Albert, John Bragg and Jason Brooks.

Description: This paper proposes a new method to price the longevity risk premia in order to tackle the pricing obstacle. Based on the equivalent utility pricing principle, our method obtains the minimum risk premium required by the longevity insurance seller and the maximum acceptable risk premium by the longevity insurance buyer.

Description: This is the abstract for the paper, The Need for Coordinated Care for Depression, and the Need for Creative Innovation by Stephen P. Melek, FSA.

Description: Discussion of “Health Expectancy” paper and reply from author, Faye Albert. Discussion of Human Behavior: An Impediment to Future Mortality and Discussion of Health, Wealth and Wisdom - Living Long, Living Well: An Actuary Muses on Longevity

Description: Chapter 3 describes the methods and data being used in the evaluation predictive accuracy. From A Comparative Analysis of Methods of Health Risk Assessment, M-HB96-1.

Description: This is the abstract to the paper, A Comparative Analysis of Chronic and Non-Chronic Insured Commercial Member Cost Trends.

Description: This is the abstract for the paper, The Cost and Benefits of Treating Type 2 Diabetes Mellitus as a Chronic Condition by Robert D. Lieberthal.